Australia markets closed

agilon health, inc. (AGL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
10.69-0.64 (-5.65%)
At close: 04:00PM EST
10.70 +0.01 (+0.09%)
After hours: 07:58PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 4.34B
Enterprise value 3.83B
Trailing P/E N/A
Forward P/E 59.52
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.05
Price/book (mrq)4.98
Enterprise value/revenue 0.91
Enterprise value/EBITDA -61.41

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 3-37.26%
S&P500 52-week change 311.63%
52-week high 329.44
52-week low 310.67
50-day moving average 316.23
200-day moving average 320.04

Share statistics

Avg vol (3-month) 32.79M
Avg vol (10-day) 33.07M
Shares outstanding 5406.04M
Implied shares outstanding 6406.04M
Float 8301.59M
% held by insiders 11.10%
% held by institutions 1108.48%
Shares short (14 Nov 2023) 449.33M
Short ratio (14 Nov 2023) 413.71
Short % of float (14 Nov 2023) 442.92%
Short % of shares outstanding (14 Nov 2023) 412.15%
Shares short (prior month 12 Oct 2023) 444.59M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin -2.12%
Operating margin (ttm)-4.03%

Management effectiveness

Return on assets (ttm)-4.28%
Return on equity (ttm)-9.08%

Income statement

Revenue (ttm)4.19B
Revenue per share (ttm)10.17
Quarterly revenue growth (yoy)75.00%
Gross profit (ttm)112.29M
EBITDA -123.01M
Net income avi to common (ttm)-88.59M
Diluted EPS (ttm)-0.22
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)564.22M
Total cash per share (mrq)1.39
Total debt (mrq)51.76M
Total debt/equity (mrq)5.94%
Current ratio (mrq)1.50
Book value per share (mrq)2.15

Cash flow statement

Operating cash flow (ttm)-144.99M
Levered free cash flow (ttm)-107.99M